Durgical
EN
Open the app

Radiation oncology: principles for doctors

  • Topic

Up to half of people with cancer need radiotherapy. Knowing how it kills, why it is split into sessions and what harm to expect helps you refer early.

Updated

What it is

Radiation oncology treats cancer with ionising radiation, given from outside the body (external beam), from sources placed in or next to the tumour (brachytherapy) or as radioactive drugs. Radiation breaks DNA, and cells that cannot repair it die when they next divide. Treatment is planned to give the tumour more damage than the surrounding normal tissue can be allowed to take, and it is used with curative or palliative intent, alone or with surgery and chemotherapy.

Key facts

  • External beam: a linear accelerator delivers photons or electrons; protons deposit their energy at a set depth with little exit dose. 3D-conformal, intensity-modulated (IMRT) and image-guided (IGRT) techniques shape the dose around the tumour.
  • Stereotactic radiotherapy (radiosurgery in the brain, SBRT in the body) gives a few large, very precise treatments to small targets; it relies on precision rather than fractionation to spare normal tissue.
  • Brachytherapy: intracavitary (cervix), interstitial seeds (prostate) or surface applicators; the dose falls steeply away from the source.
  • Curative uses: definitive radiotherapy (often with concurrent chemotherapy, as in cervical and head and neck cancer), adjuvant after surgery (breast after conserving surgery) and neoadjuvant before it (rectal cancer).
  • Palliative uses: bone pain, spinal cord compression, brain metastases, bleeding, airway or vena cava obstruction; short courses are preferred.
  • Each tissue has a lifetime tolerance, so re-irradiating the same area is limited, though another area can still be treated.

Step by step

  1. Radiation ionises water and DNA in every cell in the beam, producing free radicals.
  2. Oxygen makes the damage permanent; DNA double-strand breaks follow.
  3. Cells with unrepaired breaks die when they try to divide (mitotic catastrophe) or by apoptosis.
  4. Between sessions normal cells repair sublethal damage better than tumour cells (repair).
  5. Surviving tumour cells move into more sensitive phases of the cell cycle (redistribution) and hypoxic cells get oxygen back (reoxygenation).
  6. Tumour and normal cells regrow during gaps (repopulation), so unplanned breaks reduce tumour control.
  7. Fast-renewing tissues lose cells first (acute effects); slow tissues and small vessels scar later (late effects).

Acute versus late toxicity, by organ in the field

Organ in the fieldAcute (during treatment and weeks after)Late (months to years)
SkinErythema, dry then moist desquamation, hair loss in the fieldFibrosis, telangiectasia, pigment change, poor healing
Mouth, throat, salivary glandsMucositis, pain on swallowing, taste lossDry mouth, dental caries, osteoradionecrosis of the jaw, hypothyroidism after neck treatment
LungCough; radiation pneumonitis after weeks to monthsPulmonary fibrosis
HeartPericarditis (rare)Coronary, valve, pericardial and conduction disease
Bowel, rectum, bladderDiarrhoea, proctitis, frequency and dysuriaStrictures, bleeding from telangiectasia, fistula, small bladder
Brain and spinal cordFatigue, headache, oedemaRadiation necrosis, cognitive decline, myelopathy
Bone marrow and gonadsFalling blood counts when much marrow is treatedInfertility; second cancers in the field

Clinical notes

  • Refer early: radiotherapy often works best before or with other treatments, and planning takes time.
  • In Colombia an estimated 42–53% of new cancer patients need radiotherapy as part of first treatment, but linear accelerators and specialists are concentrated in the five largest cities and some regions have none, so travel and lodging need planning.
  • Before head and neck radiotherapy, a dental assessment and needed extractions reduce later osteoradionecrosis.
  • Check for pregnancy and implanted cardiac devices before planning; ask about previous radiotherapy to the same area.
  • A sharply bordered rash or inflammation that matches an old radiation field after a new drug is radiation recall; the trigger is usually stopped and the reaction settles.
  • The nursing side (skin care, sealed and unsealed sources, safety for staff and family) is on the nursing radiotherapy pages.

Common traps

  • Radiation kills tumour cells immediately: most cells die only when they next try to divide, so tumours shrink over weeks and keep shrinking after the course
  • Splitting the treatment into sessions is only for comfort: fractionation exploits the four Rs, letting normal tissue repair between sessions while hypoxic tumour cells reoxygenate
  • A rest break from side effects does no harm: surviving tumour cells repopulate during gaps, so unplanned interruptions lower the chance of control
  • Late toxicity is acute toxicity that never healed: they are different processes; acute effects come from fast-renewing cells and heal, late effects come from vessel damage and fibrosis and often last
  • Inflammation in an old radiation field after new chemotherapy is an infection or allergy: it is radiation recall, and its sharp edge follows the old field

Test yourself

Think of the answer, then tap the question to see it.

Why are hypoxic tumour cells more resistant to radiation?

Oxygen reacts with the radiation-induced free radicals on DNA and makes the damage permanent. Without oxygen more damage is repaired, so hypoxic cells survive.

Which are the four Rs of radiobiology, and which one makes unplanned treatment breaks harmful?

Repair, redistribution, reoxygenation and repopulation. Repopulation: surviving tumour cells regrow during gaps, lowering the chance of control.

What is the main physical difference between external beam radiotherapy and brachytherapy?

External beam comes from a machine outside the body; brachytherapy places a sealed source in or next to the tumour, so the dose is high there and falls steeply in nearby tissue.

A woman treated with breast radiotherapy two years ago develops a red, sharply bordered rash exactly over the old field after starting a new chemotherapy drug. What is it?

Radiation recall: a drug-triggered inflammatory reaction in previously irradiated tissue, most often the skin; it usually settles once the trigger is stopped.

Why do skin and mucosal reactions appear during radiotherapy while fibrosis appears months to years later?

Acute reactions come from fast-renewing cells dying in the field and heal as stem cells repopulate; late effects come from slow damage to small vessels and fibroblasts, which leads to permanent scarring.

Add to my cards (5)

More Pathology questions →

Elsewhere in DurgiPedia

Connections

← All of general pathology

Educational content on the mechanisms of disease; not a diagnostic or treatment guide and no substitute for a health professional's advice. No doses are given.

Sources: Radiation Therapy to Treat Cancer (National Cancer Institute (NCI), 2026); Radiation Therapy (StatPearls (NCBI Bookshelf), 2022); Adverse Effects of Radiation Therapy (StatPearls (NCBI Bookshelf), 2025); Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules? (Journal of Radiation Research, PubMed Central, 2016); Delayed Radiation Recall in Patients Receiving Cabozantinib: A Case Report and Review of the Literature (Advances in Radiation Oncology, PubMed Central, 2024); Estimation of the Need for Radiation Therapy Services According to the Incidence of Cancer in Colombia to 2035 (Advances in Radiation Oncology, PubMed Central, 2021).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.